TY - JOUR
T1 - Towards better reporting of the proportion of days covered method in cardiovascular medication adherence
T2 - A scoping review and new tool TEN-SPIDERS
AU - Dalli, Lachlan L.
AU - Kilkenny, Monique F.
AU - Arnet, Isabelle
AU - Sanfilippo, Frank M.
AU - Cummings, Doyle M.
AU - Kapral, Moira K.
AU - Kim, Joosup
AU - Cameron, Jan
AU - Yap, Kevin Y.
AU - Greenland, Melanie
AU - Cadilhac, Dominique A.
N1 - Funding Information:
L.L.D. reported receiving restricted educational grants from GlaxoSmithKline outside the submitted work. M.F.K. reported receiving restricted educational grants from Amgen and GlaxoSmithKline outside the submitted work. D.A.C reported receiving restricted educational grants from Amgen, Boehringer Ingelheim, Ipsen, Medtronic and Shire outside the submitted work. All other authors report no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Funding Information:
L.L.D. received scholarship support through the Australian Government Research Training Program. D.A.C. received research fellowship support from the National Health and Medical Research Council (#1154273). M.F.K. received fellowship support from the National Heart Foundation of Australia (#105737). M.K.K. holds the Lillian Love Chair in Women's Health from the University Health Network/University of Toronto. We thank Ms Anne Young (Monash University Subject Librarian) for assistance with the initial search strategy and Ms Ailie Sanders (Health Information Management Student, La Trobe University) for checking the accuracy of extracted data.
Publisher Copyright:
© 2022 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
PY - 2022/10
Y1 - 2022/10
N2 - Although medication adherence is commonly measured in electronic datasets using the proportion of days covered (PDC), no standardized approach is used to calculate and report this measure. We conducted a scoping review to understand the approaches taken to calculate and report the PDC for cardiovascular medicines to develop improved guidance for researchers using this measure. After prespecifying methods in a registered protocol, we searched Ovid Medline, Embase, Scopus, CINAHL Plus and grey literature (1 July 2012 to 14 December 2020) for articles containing the terms “proportion of days covered” and “cardiovascular medicine”, or synonyms and subject headings. Of the 523 articles identified, 316 were reviewed in full and 76 were included (93% observational studies; 47% from the USA; 2 grey literature articles). In 45 articles (59%), the PDC was measured from the first dispensing/claim date. Good adherence was defined as 80% PDC in 61 articles, 56% of which contained a rationale for selecting this threshold. The following parameters, important for deriving the PDC, were often not reported/unclear: switching (53%), early refills (45%), in-hospital supplies (45%), presupply (28%) and survival (7%). Of the 46 articles where dosing information was unavailable, 59% reported how doses were imputed. To improve the transparent and systematic reporting of the PDC, we propose the TEN-SPIDERS tool, covering the following PDC parameters: Threshold, Eligibility criteria, Numerator and denominator, Survival, Presupply, In-hospital supplies, Dosing, Early Refills, and Switching. Use of this tool will standardize reporting of the PDC to facilitate reliable comparisons of medication adherence estimates between studies.
AB - Although medication adherence is commonly measured in electronic datasets using the proportion of days covered (PDC), no standardized approach is used to calculate and report this measure. We conducted a scoping review to understand the approaches taken to calculate and report the PDC for cardiovascular medicines to develop improved guidance for researchers using this measure. After prespecifying methods in a registered protocol, we searched Ovid Medline, Embase, Scopus, CINAHL Plus and grey literature (1 July 2012 to 14 December 2020) for articles containing the terms “proportion of days covered” and “cardiovascular medicine”, or synonyms and subject headings. Of the 523 articles identified, 316 were reviewed in full and 76 were included (93% observational studies; 47% from the USA; 2 grey literature articles). In 45 articles (59%), the PDC was measured from the first dispensing/claim date. Good adherence was defined as 80% PDC in 61 articles, 56% of which contained a rationale for selecting this threshold. The following parameters, important for deriving the PDC, were often not reported/unclear: switching (53%), early refills (45%), in-hospital supplies (45%), presupply (28%) and survival (7%). Of the 46 articles where dosing information was unavailable, 59% reported how doses were imputed. To improve the transparent and systematic reporting of the PDC, we propose the TEN-SPIDERS tool, covering the following PDC parameters: Threshold, Eligibility criteria, Numerator and denominator, Survival, Presupply, In-hospital supplies, Dosing, Early Refills, and Switching. Use of this tool will standardize reporting of the PDC to facilitate reliable comparisons of medication adherence estimates between studies.
KW - cardiovascular disease
KW - drug utilization
KW - medication adherence
KW - methods
KW - pharmacoepidemiology
KW - scoping review
UR - http://www.scopus.com/inward/record.url?scp=85130218387&partnerID=8YFLogxK
U2 - 10.1111/bcp.15391
DO - 10.1111/bcp.15391
M3 - Review Article
C2 - 35524398
AN - SCOPUS:85130218387
VL - 88
SP - 4427
EP - 4442
JO - British Journal of Clinical Pharmacology
JF - British Journal of Clinical Pharmacology
SN - 0306-5251
IS - 10
ER -